LXEO 8-K 2026-09-29
Lexeo Therapeutics, Inc. (LXEO) 8-K dated 2026-09-29 — accession 0001193125-26-407555.
Lexeo Therapeutics, Inc. (LXEO) is a biotechnology company listed on US.
Lexeo Therapeutics, Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-407555.
This 8-K covers: Acquisition or disposition (Item 2.01), Unregistered share sale (Item 3.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported LXEO revenue for 2022-12-31 was $654.0K. Net income was $59.3M. LXEO currently screens at market cap $147.7M.
Not investment advice. The LXEO SEC hub lists recent forms. The stock page is the research view.